Timing-wise they are just about exactly the same. Nevada reinstatements were only one day apart and then OTCMarket disclosures both started on the same day, 3/15. There is no concrete reason at the moment to think one would be closer than the other to a merger.
Share structure is where we see a little bit of differentiation.
CYPE just raised it's OS to 272m of which the new 200m are the restricted control block presumably to be handed over to the new owners. Of the remaining 72m, 26m are unrestricted common owned by Johannes Petersen, CYPE's old Secretary, Treasurer and Director (Principal Financial Officer and Principal Accounting Officer). No preferred shares have been issued.
AXMP just raised it's OS to 408m of which the new 250m are presumably the restricted control block to be handed to the new owners. Of the remaining 158m, 100m are unrestricted common owned by Joseph Arcaro himself. Joseph also owns all 3m preferred shares that have been issued.
If trading at the same price level CYPE does appear to give you more bang for your buck over AXMP. On the other hand, I think it would be a mistake to ignore all the shares Joe owns of AXMP as we go into a merger. If he has multiple merger prospects at the same time it's certainly not crazy to consider he might want the bigger/better company in the one he stands to profit more personally from.
I could be wrong.
I own both. :)
AI
